Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,636.00
Bid: 2,628.00
Ask: 2,630.00
Change: 34.00 (1.31%)
Spread: 2.00 (0.076%)
Open: 2,622.00
High: 2,656.00
Low: 2,614.00
Prev. Close: 2,602.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Composition of the Committees of the BoD of CCHBC

11 Jun 2018 15:20

RNS Number : 0152R
Coca-Cola HBC AG
11 June 2018
 

 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca‑Cola HBC AG

 

 

Zug, Switzerland - 11 June 2018 - Coca‑Cola HBC AG ("Coca‑Cola HBC" or the "Company") announces today that its board of directors (the "Board") has re-appointed all members of the Board Committees.

These re-appointments have been made pursuant to the announcement released by Coca‑Cola HBC on 8 May 2018.

The composition of the Board Committees will be as follows:

Audit Committee

William (Bill) W. Douglas III (Chair)

John P. Sechi

Olusola (Sola) David-Borha

Nomination Committee

Reto Francioni (Chair)

Charlotte J. Boyle

Alexandra Papalexopoulou

Remuneration Committee

Alexandra Papalexopoulou (Chair)

Charlotte J. Boyle

Reto Francioni

Social Responsibility Committee

Anastasios I. Leventis (Chair)

Alexandra Papalexopoulou

José Octavio Reyes

 

This announcement is made pursuant to Listing Rule 9.6.11.

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231

 basak.kotler@cchellenic.com

Joanna Kennedy

Investor Relations Manager

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Anushka Mathew

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com anushka.mathew@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAZFLFFVQFFBBQ
Date   Source Headline
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM
18th May 20223:05 pmRNSDirector/PDMR Shareholding
18th May 202212:24 pmRNSHolding(s) in Company
12th May 20227:00 amRNSStrong performance despite turbulent environment
3rd May 202210:22 amRNSIssue of equity and total voting rights
3rd May 202210:05 amRNSBlock listing Interim Review
29th Apr 20221:46 pmRNSHolding(s) in Company
20th Apr 20223:03 pmRNSDirector/PDMR Shareholding
19th Apr 202210:06 amRNSNotice of Results
12th Apr 20225:38 pmRNSMove to organic reporting
1st Apr 20223:58 pmRNSDirector/PDMR Shareholding
1st Apr 20223:47 pmRNSDirector/PDMR Shareholding
1st Apr 202211:46 amRNSIssue of equity and total voting rights
23rd Mar 202212:23 pmRNSAnnual Financial Report
18th Mar 20222:02 pmRNSDirector/PDMR Shareholding
16th Mar 20223:43 pmRNSDirector/PDMR Shareholding
16th Mar 202212:56 pmRNSDirector/PDMR Shareholding
14th Mar 202210:57 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSUkraine and Russia update
3rd Mar 20224:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSUkraine and Russia conflict update
22nd Feb 20227:00 amRNSSTRONG EXECUTION DRIVES GROWTH MOMENTUM
18th Feb 20222:45 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:57 amRNSNotice of Results
1st Feb 20228:20 amRNSIssue of equity and total voting rights
25th Jan 202212:50 pmRNSCompletes acquisition of further stake in CCBCE
18th Jan 20222:20 pmRNSDirector/PDMR Shareholding
13th Jan 20228:53 amRNSCompletes acquisition of a majority stake in CCBCE
7th Jan 20222:14 pmRNSAthens Exchange trading date of ordinary shares
4th Jan 202210:55 amRNSIssue of equity and total voting rights
4th Jan 20229:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.